Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.
Over the last 12 months, insiders at Enanta Pharmaceuticals, Inc. have bought $0 and sold $605,204 worth of Enanta Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Enanta Pharmaceuticals, Inc. have bought $0 and sold $2.77M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,000 shares for transaction amount of $24,445 was made by Gardiner Nathaniel S. (Sr. VP & General Counsel) on 2016‑05‑11.
2024-07-15 | Sale | Chief Medical Officer | 5,375 0.0355% | $17.08 | $91,805 | 0.00% | ||
2024-07-12 | Sale | Chief Medical Officer | 2,271 0.0132% | $15.04 | $34,156 | 0.00% | ||
2024-07-11 | Sale | Chief Medical Officer | 4,299 0.0251% | $15.07 | $64,786 | 0.00% | ||
2024-06-17 | Sale | Chief Product Strategy Officer | 7,266 0.0315% | $12.33 | $89,590 | -2.15% | ||
2023-12-13 | Sale | director | 15,295 0.0684% | $9.12 | $139,490 | +28.58% | ||
2023-12-05 | Sale | President and CEO | 7,230 0.0351% | $9.63 | $69,625 | +31.12% | ||
2023-12-05 | Sale | Sr. VP, R&D & CSO | 2,412 0.0117% | $9.63 | $23,228 | +31.12% | ||
2023-12-05 | Sale | Sr. VP, Finance & Admin. & CFO | 2,412 0.0117% | $9.63 | $23,228 | +31.12% | ||
2023-12-05 | Sale | Sr. VP & General Counsel | 2,412 0.0117% | $9.63 | $23,228 | +31.12% | ||
2023-12-05 | Sale | Sr. VP, New Prod. Strat. & Dev | 2,125 0.0103% | $9.63 | $20,464 | +31.12% | ||
2023-12-05 | Sale | Sr. VP, Business Dev. | 2,125 0.0103% | $9.63 | $20,464 | +31.12% | ||
2023-12-05 | Sale | Sr. VP & CMO | 534 0.0026% | $9.63 | $5,142 | +31.12% | ||
2023-03-15 | Sale | Sr. VP & CSO | 13,925 0.0661% | $44.45 | $618,960 | -67.56% | ||
2023-03-15 | Sale | Treasurer and CFO | 10,440 0.0495% | $44.43 | $463,802 | -67.56% | ||
2023-03-13 | Sale | President and CEO | 27,912 0.133% | $45.16 | $1.26M | -67.30% | ||
2023-02-09 | Sale | Treasurer and CFO | 5,000 0.0241% | $53.76 | $268,816 | -70.01% | ||
2022-12-16 | Sale | President and CEO | 30,000 0.1421% | $44.72 | $1.34M | -48.24% | ||
2022-04-01 | Sale | Sr. VP & Chief Medical Officer | 18,076 0.0872% | $71.71 | $1.3M | -31.68% | ||
2022-03-21 | Sale | 2,676 0.0131% | $66.70 | $178,489 | -25.35% | |||
2022-03-02 | Sale | Sr. VP & Chief Medical Officer | 12,481 0.0609% | $70.07 | $874,544 | -27.80% |
Luly Jay R. | President and CEO | 806793 3.8067% | $8.66 | 0 | 17 | |
Or Yat Sun | Sr. VP, R&D & CSO | 370695 1.749% | $8.66 | 0 | 18 | |
MELLETT PAUL J | Sr. VP, Finance & Admin. & CFO | 93549 0.4414% | $8.66 | 0 | 20 | |
Gardiner Nathaniel S. | Sr. VP & General Counsel | 68154 0.3216% | $8.66 | 3 | 2 | +9.2% |
Luu Brendan | Sr. VP, Business Dev. | 36736 0.1733% | $8.66 | 0 | 1 | |
Kieffer Tara Lynn | Chief Product Strategy Officer | 32341 0.1526% | $8.66 | 0 | 2 | |
Rottinghaus Scott T. | Chief Medical Officer | 21717 0.1025% | $8.66 | 0 | 4 | |
Vance Terry | director | 5800 0.0274% | $8.66 | 2 | 1 | +8.96% |
Goldberg Marc E. | director | 547606 2.5837% | $8.66 | 0 | 3 | |
SCHUHSLER HELMUT | 380487 1.7952% | $8.66 | 1 | 3 | +19.31% | |
TVM V LIFE SCIENCE VENTURES GMBH & CO KG | 10 percent owner | 276999 1.307% | $8.66 | 1 | 7 | +19.31% |
Adda Nathalie | Sr. VP & Chief Medical Officer | 47191 0.2227% | $8.66 | 0 | 14 | |
AFTING ERNST-GUENTER | director | 17287 0.0816% | $8.66 | 0 | 1 | |
SAINTS CAPITAL GRANITE, L.P. | 10 percent owner | 16904 0.0798% | $8.66 | 1 | 8 | +19.31% |
Ocain Tim | Senior Vice President | 6127 0.0289% | $8.66 | 0 | 1 | |
CARTER BRUCE L A | 3324 0.0157% | $8.66 | 0 | 4 | ||
Verdine Gregory L. | director | 3324 0.0157% | $8.66 | 1 | 0 | +19.31% |
Buckley Stephen Jr. | director | 2000 0.0094% | $8.66 | 3 | 0 | +6.42% |
Golumbeski George | director | 0 0% | $8.66 | 0 | 3 |
Farallon Capital | $36.58M | 9.89 | 2.1M | +3.46% | +$1.22M | 0.26 | |
Morgan Stanley | $35.71M | 9.66 | 2.05M | +74.34% | +$15.23M | <0.01 | |
The Vanguard Group | $33.66M | 9.1 | 1.93M | +7.49% | +$2.34M | <0.01 | |
BlackRock | $32.11M | 8.68 | 1.84M | -4.94% | -$1.67M | <0.01 | |
Armistice Capital Llc | $21.58M | 5.84 | 1.24M | -40.12% | -$14.46M | 0.07 | |
Krensavage Asset Management LLC | $19.64M | 5.31 | 1.12M | +51.39% | +$6.67M | 9.91 | |
Marshall Wace | $16.61M | 4.49 | 951,062 | New | +$16.61M | 0.02 | |
Northern Trust | $16.3M | 4.41 | 933,356 | -0.23% | -$37,312.02 | <0.01 | |
Caligan Partners LP | $14.98M | 4.05 | 858,070 | New | +$14.98M | 3.96 | |
Acadian Asset Management | $14.91M | 4.03 | 853,896 | +1.3% | +$191,183.13 | 0.05 | |
Millennium Management LLC | $12.33M | 3.34 | 706,248 | -7.7% | -$1.03M | 0.01 | |
Assenagon Asset Management S.A. | $10.19M | 2.76 | 583,658 | 0% | +$0 | 0.03 | |
Soleus Capital Management, L.P. | $10.14M | 2.74 | 580,546 | New | +$10.14M | 0.04 | |
D. E. Shaw & Co. | $9.96M | 2.69 | 570,246 | -10.64% | -$1.19M | 0.01 | |
Renaissance Technologies | $9.19M | 2.48 | 526,100 | -5.8% | -$565,722.11 | 0.02 | |
Bank of America | $9.02M | 2.44 | 516,366 | +4,111.79% | +$8.8M | <0.01 | |
Geode Capital Management | $7.72M | 2.09 | 442,072 | +2.99% | +$224,124.97 | <0.01 | |
State Street | $7.4M | 2 | 423,965 | -0.39% | -$29,245.50 | <0.0001 | |
Boothbay Fund Management LLC | $6.78M | 1.84 | 388,600 | New | +$6.78M | 0.22 | |
Tang Capital Management, LLC | $5.24M | 1.42 | 300,000 | 0% | +$0 | 0.02 | |
Two Sigma Advisers LP | $4.92M | 1.33 | 282,000 | -3.03% | -$153,648.00 | 0.01 | |
Two Sigma | $4.49M | 1.22 | 257,309 | -22.55% | -$1.31M | 0.01 | |
Ubs Asset Management Americas Inc | $3.63M | 0.98 | 208,089 | -7.13% | -$279,010.80 | <0.01 | |
Jacobs Levy Equity Management | $3.4M | 0.92 | 194,730 | -65.29% | -$6.4M | 0.01 | |
Dimensional Fund Advisors | $3.3M | 0.89 | 189,256 | +5.4% | +$169,239.74 | <0.01 | |
Sio Capital Management LLC | $3.09M | 0.84 | 177,004 | New | +$3.09M | 1.11 | |
Prudential Financial | $3.01M | 0.81 | 172,264 | -11% | -$371,897.95 | <0.01 | |
Charles Schwab | $2.81M | 0.76 | 161,000 | +9.28% | +$238,660.74 | <0.01 | |
JPMorgan Chase | $2.41M | 0.65 | 138,047 | -8.47% | -$223,034.08 | <0.0001 | |
AQR Capital | $1.92M | 0.52 | 109,706 | -46.03% | -$1.63M | <0.01 | |
Qube Research & Technologies | $1.79M | 0.49 | 102,625 | -45.65% | -$1.51M | <0.01 | |
Trexquant Investment LP | $1.67M | 0.45 | 95,639 | -19.37% | -$401,108.59 | 0.03 | |
Goldman Sachs | $1.58M | 0.43 | 90,690 | -51.41% | -$1.68M | <0.0001 | |
Nuveen | $1.56M | 0.42 | 89,387 | +60.75% | +$589,798.79 | <0.0001 | |
SEI Investments Company | $1.54M | 0.42 | 88,155 | 0% | +$0 | <0.01 | |
Federated Hermes | $1.54M | 0.42 | 88,172 | -33.8% | -$785,996.76 | <0.01 | |
BNY Mellon | $1.14M | 0.31 | 65,196 | -10.23% | -$129,727.33 | <0.0001 | |
Citadel Advisors LLC | $970,130.00 | 0.26 | 55,563 | -16.38% | -$190,017.18 | <0.01 | |
Connor Clark & Lunn Investment Management Ltd | $779,222.00 | 0.21 | 44,629 | +7.89% | +$56,989.42 | <0.01 | |
Invesco | $759,492.00 | 0.21 | 43,499 | +115% | +$406,241.53 | <0.0001 | |
PDT Partners | $693,633.00 | 0.19 | 39,727 | -37.17% | -$410,274.83 | 0.05 | |
Fidelity Investments | $688,291.00 | 0.19 | 39,421 | +28.55% | +$152,879.84 | <0.0001 | |
Pennant Capital Management Llc | $612,846.00 | 0.17 | 35,100 | 0% | +$0 | 0.1 | |
RhumbLine Advisers | $576,479.00 | 0.16 | 33,018 | +2.18% | +$12,291.51 | <0.01 | |
Ameriprise Financial | $556,503.00 | 0.15 | 31,873 | -65.95% | -$1.08M | <0.0001 | |
Franklin Templeton Investments | $507,493.00 | 0.14 | 29,066 | New | +$507,493.00 | <0.0001 | |
AllianceBernstein | $487,658.00 | 0.13 | 27,930 | 0% | +$0 | <0.0001 | |
Cubist Systematic Strategies | $477,483.00 | 0.13 | 27,347 | -66.96% | -$967,642.08 | <0.01 | |
Point72 Asia Singapore Pte Ltd | $440,163.00 | 0.12 | 25,210 | +2,000.83% | +$419,211.17 | 0.04 | |
Wells Fargo | $434,910.00 | 0.12 | 24,909 | +303.19% | +$327,042.40 | <0.0001 |